MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits

MPR Drug News

Recall: Antipsychotic Found in Bottle Labeled for GERD Medication

AstraZeneca announced a voluntary recall of 34,524 bottles of Nexium (esomeprazole magnesium) delayed-release capsules following the discovery of a bottle containing Seroquel XR (quetiapine fumarate) extended-release tablets instead.

Gene Therapy Found to Improve Lung Function in CF

Gene therapy showed a significant benefit in lung function in patients with cystic fibrosis, data from a Phase 2 trial has shown.

Statins Linked to Aggression in Women, But Not Men

The effect of statins on aggression appears to differ based on sex and age, as a study published in PLOS ONE found that aggression increased in postmenopausal women taking statins but actually decreased in men.

FDA Approves Unique Treatment for Cystic Fibrosis

The Food and Drug Administration (FDA) has approved Orkambi (lumacaftor/ivacaftor; Vertex), the first and only drug indicated for the treatment of cystic fibrosis (CF) in patients aged ≥12 who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Teva Launches Generic Aggrenox

Teva announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, the generic version of Aggrenox Capsules.